SCHEMBL25200049

SCHEMBL25200049

CC(C)(COC(=O)N[C@H](C(=O)O)C(C)(C)C)c1cccc(Cl)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.42
CTSL P07711 2/20 0.40
CTSB P07858 1/20 0.40
CTSH P09668 1/20 0.40
CTSS P25774 1/20 0.40
CTSK P43235 1/20 0.40
NPC1 O15118 1/20 0.40
ALDH1A1 P00352 1/20 0.40
GAA P10253 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
GRIN2D O15399 1/20 0.40
GRIN3B O60391 1/20 0.40
GRIN1 Q05586 1/20 0.40
GRIN2A Q12879 1/20 0.40
GRIN2B Q13224 1/20 0.40
GRIN2C Q14957 1/20 0.40
GRIN3A Q8TCU5 1/20 0.40
KIF11 P52732 2/20 0.39
CNR1 P21554 3/20 0.38
CNR2 P34972 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30174654 1.00 MAPT (0.42) MAPTCTSLCTSBCTSHCTSS
SCHEMBL25221056 1.00 MAPT (0.42) MAPTCTSLCTSBCTSHCTSS
SCHEMBL28951840 0.92 MAPT (0.42) MAPTCTSLCTSBCTSHCTSS
SCHEMBL30428422 0.92 MAPT (0.42) MAPTCTSLCTSBCTSHCTSS
SCHEMBL28951838 0.92 MAPT (0.42) MAPTCTSLCTSBCTSHCTSS
SCHEMBL24740258 0.85 MAPT (0.47) MAPTCTSLCTSBCTSHCTSS
SCHEMBL25234274 0.83 MAPK1 (0.54) MAPTCTSLCTSBCTSHCTSS
SCHEMBL30174749 0.83 MAPK1 (0.54) MAPTCTSLCTSBCTSHCTSS
SCHEMBL25527528 0.83 MAPK1 (0.54) MAPTCTSLCTSBCTSHCTSS
SCHEMBL24112753 0.81 MAPT (0.44) MAPTNPC1ALDH1A1GAANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230159453-A1 INHIBITORS OF NOROVIRUS AND CORONAVIRUS REPLICATION COCRYSTAL PHARMA, INC. 2023-05-25 US disclosed
CN-115698035-A Inhibitors of norovirus and coronavirus replication 共晶制药公司 2023-02-03 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230159453-A1 INHIBITORS OF NOROVIRUS AND CORONAVIRUS REPLICATION VIM, ACE, ACE2 MAPT 1072/4885CTSL 1031/4885CTSB 1058/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.